tilavonemab (ABBV-8E12) - AbbVie
https://alz.confex.com/alz/2023/meetingapp.cgi/Paper/78874
 
Aparna Vasanthakumar, PhD1; Qian Gao, PhD2; Paula Daunt, PhD3; Simon Flint, PhD4; Alex Gibson, PhD2; Hana Florian, MD5; Jeffrey Waring, PhD1
 
Jul 7, 2023
 
Prev Next